Literature DB >> 36258081

Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

Laura Camus1, Paul Briaud1, François Vandenesch1,2, Anne Doléans-Jordheim1,2, Karen Moreau3.   

Abstract

The human pathogens Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated from chronic wounds or cystic fibrosis patient airways. Clinical studies analysing the impact of co-infection on patient clinical outcomes lead to contradictory results. However, laboratory approaches suggest that the two pathogens co-colonize the same infection niches and form a mixed-species biofilm, therefore favouring their resistance to antibiotics and immune response. In parallel, many recent studies have focused on the different interactions between the two bacterial species. It has long been recognized that P. aeruginosa usually outcompetes S. aureus, and the molecular mechanisms involved in this state of bacterial competition are now well understood. However, several recent studies show that interactions between P. aeruginosa and S. aureus can be diverse and evolve over time. Thus, many CF isolates of P. aeruginosa and S. aureus can coexist and develop cooperative behaviours. In this chapter, we will provide an overview of the current knowledge on the mixed populations of P. aeruginosa and S. aureus, from their mechanisms of establishment to their impacts on bacterial physiology and clinical outcomes.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Bacterial interaction; Clinical outcomes; Co-infection; Coexistence; Competition; Host response; Mixed biofilm; Pseudomonas aeruginosa; Staphylococcus aureus

Mesh:

Substances:

Year:  2022        PMID: 36258081     DOI: 10.1007/978-3-031-08491-1_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  130 in total

Review 1.  Updates on the pathogenicity status of Pseudomonas aeruginosa.

Authors:  Mohd W Azam; Asad U Khan
Journal:  Drug Discov Today       Date:  2018-07-20       Impact factor: 7.851

2.  Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa.

Authors:  Lalitha Biswas; Raja Biswas; Martin Schlag; Ralph Bertram; Friedrich Götz
Journal:  Appl Environ Microbiol       Date:  2009-08-28       Impact factor: 4.792

3.  Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus.

Authors:  Federico C Beasley; Enrique D Vinés; Jason C Grigg; Qin Zheng; Suya Liu; Gilles A Lajoie; Michael E P Murphy; David E Heinrichs
Journal:  Mol Microbiol       Date:  2009-04-14       Impact factor: 3.501

4.  Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.

Authors:  Heather G Ahlgren; Andrea Benedetti; Jennifer S Landry; Joanie Bernier; Elias Matouk; Danuta Radzioch; Larry C Lands; Simon Rousseau; Dao Nguyen
Journal:  BMC Pulm Med       Date:  2015-06-21       Impact factor: 3.317

5.  Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection.

Authors:  Irene Bianconi; Julie Jeukens; Luca Freschi; Beatriz Alcalá-Franco; Marcella Facchini; Brian Boyle; Antonio Molinaro; Irena Kukavica-Ibrulj; Burkhard Tümmler; Roger C Levesque; Alessandra Bragonzi
Journal:  BMC Genomics       Date:  2015-12-29       Impact factor: 3.969

6.  Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection.

Authors:  Rossella Baldan; Cristina Cigana; Francesca Testa; Irene Bianconi; Maura De Simone; Danilo Pellin; Clelia Di Serio; Alessandra Bragonzi; Daniela M Cirillo
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 7.  Bacterial Quorum Sensing and Microbial Community Interactions.

Authors:  Rhea G Abisado; Saida Benomar; Jennifer R Klaus; Ajai A Dandekar; Josephine R Chandler
Journal:  mBio       Date:  2018-05-22       Impact factor: 7.867

8.  Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance.

Authors:  T Beaudoin; Y C W Yau; P J Stapleton; Y Gong; P W Wang; D S Guttman; V Waters
Journal:  NPJ Biofilms Microbiomes       Date:  2017-10-19       Impact factor: 7.290

9.  Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study.

Authors:  Irene Bianconi; Silvia D'Arcangelo; Alfonso Esposito; Mattia Benedet; Elena Piffer; Grazia Dinnella; Paola Gualdi; Michele Schinella; Ermanno Baldo; Claudio Donati; Olivier Jousson
Journal:  Front Microbiol       Date:  2019-01-11       Impact factor: 5.640

10.  Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa.

Authors:  Catherine R Armbruster; Daniel J Wolter; Meenu Mishra; Hillary S Hayden; Matthew C Radey; Gennifer Merrihew; Michael J MacCoss; Jane Burns; Daniel J Wozniak; Matthew R Parsek; Lucas R Hoffman
Journal:  mBio       Date:  2016-05-24       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.